Massachusetts Governor Deval Patrick to address BioPharm America™ 2011

BOSTON--(BUSINESS WIRE)-- EBD Group and MassBio today announced that Massachusetts Governor Deval Patrick will make a special visit to BioPharm America 2011. Governor Patrick will address leaders in the global life science industry during an event at The State Room at 60 State Street in Boston on Wednesday, September 7 at 7:00 pm.

“We are honored to have Governor Deval Patrick address the BioPharm America delegation,” said Bob Coughlin, President and CEO of MassBio. “The life science industry is vital part of Massachusetts’ economic fabric. This event is a unique opportunity to highlight how our companies continue to be the most innovative in the industry.”

Carola Schropp, President of EBD Group, the leading partnering firm in the life science industry added, “The BioPharm America conference is one of the largest business exchanges in the world. It is where the leading dealmakers come to strike the deals and collaborations resulting in tomorrow’s novel medicines. Governor Patrick is one of the most important advocates for our industry and we are excited to have him speak at our event.”

On June 16, 2008, Governor Patrick signed into law his groundbreaking 10-year, USD 1 billion Life Sciences Initiative, positioning Massachusetts as a global leader in life sciences and bringing together research hospitals, businesses, and universities to enhance the state's nationally-recognized strengths in medicine and science.

“We want Massachusetts to provide the global platform for bringing innovations from the drawing board to the market, from inspiration to commercialization, and from ideas to cures,” said Patrick in 2007, when introducing his bill.

With more than 1,000 dealmakers expected, BioPharm America is the only event in North America based on the same reputable formula as EBD Group's acclaimed European events BIO-Europe® and BIO-Europe Spring®, and was specifically designed to help companies form in- or out-licensing agreements and co-development deals, and raise capital.

MassBio estimates that 1,273 biotechnology drugs were being developed in Massachusetts in 2010, representing almost eight percent of the global drug pipeline. In 2010, Massachusetts companies garnered more than 23 percent of all of the biotechnology venture capital funding in the US, an all-time high.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world.

Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.

About MassBio

MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and service.

For more information please visit www.massbio.org.



CONTACT:

EBD Group
Tilton Little, +1 760-930-0500
Senior Manager, PR and Social Media
M: +1 619-379-1786
[email protected]

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Health  Biotechnology  Cardiology  Clinical Trials  Infectious Diseases  Public Policy/Government  Medical Devices  Optical  Pharmaceutical  Radiology  Other Government  Other Health  State/Local  Automotive  General Automotive

MEDIA:

Logo
 Logo

Suggested Articles

A Roche compound that was designed to treat rheumatoid arthritis could improve the heart's ability to repair itself, a Vanderbilt team found.

After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up…

In this week's EuroBiotech Report, Lundbeck inks $2 billion Alder buyout, Euro biotechs raise cash and blast rocks Russian smallpox lab.